NeueHealth, Inc. (NEUE)
NYSE: NEUE · IEX Real-Time Price · USD
5.30
+0.03 (0.57%)
Jul 2, 2024, 4:00 PM EDT - Market closed

NeueHealth Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Revenue
1,161751.161,5131,207280.67
Upgrade
Revenue Growth (YoY)
54.53%-50.35%25.32%330.15%114.86%
Upgrade
Cost of Revenue
996.58662.971,2941,047224.39
Upgrade
Gross Profit
164.2288.19218.88160.0256.29
Upgrade
Selling, General & Admin
287.14354.44527.45409.33180.49
Upgrade
Other Operating Expenses
454.08102.5135.058.291.13
Upgrade
Operating Expenses
741.22456.95562.5417.62181.62
Upgrade
Operating Income
-577-368.76-343.63-257.6-125.34
Upgrade
Interest Expense / Income
38.212.827.2300
Upgrade
Other Expense / Income
537.681,070860.53--
Upgrade
Pretax Income
-1,152.88-1,451.88-1,211.38-257.6-125.34
Upgrade
Income Tax
-1.433.66-26.52-9.160
Upgrade
Net Income
-1,151.45-1,455.54-1,184.86-248.44-125.34
Upgrade
Preferred Dividends
49.1539.69000
Upgrade
Net Income Common
-1,200.6-1,495.23-1,184.86-248.44-125.34
Upgrade
Shares Outstanding (Basic)
88522
Upgrade
Shares Outstanding (Diluted)
88522
Upgrade
Shares Change
1.09%60.47%188.01%1.27%1.90%
Upgrade
EPS (Basic)
-150.94-190.04-241.60-145.60-74.40
Upgrade
EPS (Diluted)
-150.94-190.04-241.60-145.60-74.40
Upgrade
Free Cash Flow
-2,729.44207.0251.65-63.71-9
Upgrade
Free Cash Flow Per Share
-343.1526.3110.53-37.42-5.35
Upgrade
Gross Margin
14.15%11.74%14.47%13.25%20.05%
Upgrade
Operating Margin
-49.71%-49.09%-22.71%-21.34%-44.66%
Upgrade
Profit Margin
-103.43%-199.06%-78.31%-20.58%-44.66%
Upgrade
Free Cash Flow Margin
-235.13%27.56%3.41%-5.28%-3.21%
Upgrade
EBITDA
-1,090.51-1,388.48-1,168.67-249.31-124.2
Upgrade
EBITDA Margin
-93.94%-184.84%-77.24%-20.65%-44.25%
Upgrade
Depreciation & Amortization
24.1750.5835.488.291.13
Upgrade
EBIT
-1,114.68-1,439.06-1,204.15-257.6-125.34
Upgrade
EBIT Margin
-96.03%-191.58%-79.59%-21.34%-44.66%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).